glp-1 ulcerative colitis and medications are a major focus for scientists right now., Here’s what’s happening: between 2024 and 2025, at least six studies have been published in respected journals Relevance of Glucagon-Like Peptide 1

I finally feel like I have control and myself back

Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, Peters C, Zhyzhneuskaya S, Al-Mrabeh A, Hollingsworth KG, et al

Exercise avoidance behaviour is a sensitive indicator of substance-induced malaise in mice 35

While the contribution of weight loss remains unclear, this study, alongside emerging preclinical data from rodent models, suggests that GLP-1 medicines may offer efficacy in inflammation-driven diseases independent of the amelioration of metabolic dysfunction

260.1 on Medkart

There is evidence showing that GLP-1RAs can reduce the expression of cell apoptotic markers Bcl-2-associated x (Bax) and caspase-3 while upregulating Bcl-2 [99, 100], as well as protecting against lipotoxic stress via phosphoinositide 3-kinase (PI3K)/Akt/forkhead box proteins O1 (FoxO1) pathway [101]